$0.4525
0.1028.51%
Last update: Oct 28, 8:34 AM

The average analyst price target for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. is $123.44, 27179.6% above the current price. Of 8 analysts, 6 rate it Buy and 2 Hold. Targets range from $1 to $340. The latest change came on Apr 8, 2026, when Maxim Group downgraded REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. from Buy to Hold.
Price Target Range — 10 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months